regulatory strategy and pathway analysis

Kinexum provides regulatory consulting services for life science products, using experience with major agencies worldwide such as FDA, EMA, and MHRA to help clients with regulatory, nonclinical, CMC, and related development and commercialization challenges. Since 2003, Kinexum has supported over 500 companies globally with a team of more than sixty subject matter experts, most holding MDs, PhDs, MBAs, or JDs, based across North America, Europe, and Asia.

Read more

CDMO selection and managementclinical supply planning and managementCMC consultingdue diligenceFDA special designationsgap analysisnonclinical study design and monitoringquality assurance and controlregulatory submissions (IND, NDA, BLA, IDE, 510(k), de novo, PMA)